Immunicum Competitors and Similar CompaniesClear all

Camurus's competitors and similar companies include GBT (Global Blood Therapeutics).
Camurus
Camurus
Camurus is a research-based pharmaceutical company that develops medicines for severe and chronic conditions.
GBT (Global Blood Therapeutics)
GBT (Global Blood Therapeutics)
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
Founding Date
Founding Date
1991
Founding Date
2012
Type
Type
Public
Type
Public
Tags
Locations
Locations
Lund, SE HQ
Sydney, AU
Mannheim, DE
Duxford, GB
Locations
South San Francisco, US HQ
Paris, FR
Berlin, DE
Baar, CH
London, GB
Employees
Employees
265
Employees
352106% increase
Valuation ($)
Valuation ($)
3.4 b
Valuation ($)
4.4 b

Financial

Revenue (est.)
Revenue (est.)
kr2.3b (FY, 2025)
Revenue (est.)
$194.7m (FY, 2021)
Cost of goods
Cost of goods
kr138.7m (FY, 2025)
Cost of goods
$3.3m (FY, 2021)
Net income
Net income
kr735.6m (FY, 2025)
Net income
($303.1m) (FY, 2021)
For sources of this data, please see the company profile

View Company Profiles

GBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352

GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.

View company